SLE ( Systemic Lupus Erythematosus )

Systemic Lupus Erythematosus ( SLE ) is the most common form of lupus. Widespread inflammation and tissue damage of joints, skin, brain, lungs, kidneys, and blood vessels occur due to the immune system attacking its own healthy tissues. Below are COVID news and research updates that specifically relate to SLE.

Side Effects & Rate of Flare-Ups in SLE Patients after COVID-19 Vaccination

A recent study cited in Lupus Science and Medicine covered vaccine safety in patients with Systemic Lupus Erythematosus. 237 vaccinated SLE participants were included, and researchers found that rates of vaccine side effects reported by those with SLE were statistically similar to those in the general public; additionally, the majority of patients did not experience disease flare-ups in response to vaccination.

Read More »

Caring for Autoimmunity & Long COVID with a Personalized Approach

The company Mymee recently published a study on their personalized digital care program for patients living with autoimmune diseases as well as long Covid. Researchers found that over 85% of patients with moderate to severe symptoms saw improvements with their anxiety, depression, fatigue, pain interference, sleep disturbance, and pain intensity while increasing cognitive and physical function.

Read More »

How COVID-19 Triggers an Autoimmune Reaction

Researchers have hypothesized how a Covid-19 infection may trigger the development of autoimmune diseases through three different mechanisms, which may intersect at different points of the inflammatory process. Various autoimmune diseases include rheumatoid arthritis, ankylosing spondylitis, Guillain-Barre syndrome, as well as Hashimoto’s and Graves disease.

Read More »